Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 5, 1998, Pages 808-815

  Lang, Irene M ^a,b,c   Moser, Kenneth M ^b   Schleef, Raymond R ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Plasminogen activator inhibitor type 1; Plasminogen activators; Pulmonary thromboembolism; Thrombus organization

Indexed keywords

ALPHA ACTIN; CD68 ANTIGEN; CYCLINE; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE; VON WILLEBRAND FACTOR;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG EMBOLISM; MALE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THROMBOEMBOLISM;

EID: 0031806281     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.5.808     Document Type: Article

References (20)

1. Lilienfeld DE, Chan E, Ehland J. Mortality from pulmonary embolism in the United States. Chest. 1990;98:1067-1072.
2. Anderson FAJ, Wheeler HB, Goldberg RJ. A population-based perspective of the hospital incidence and case-fatality rates of venous thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med. 1991:151:933-938.
3. Waagenvoort CA. Pathology of pulmonary thromboembolism. Chest. 1995;107:10s-17s.
4. Morrel MT, Dunnill MS. Fibrous bands in conducting pulmonary arteries. J Clin Pathol. 1967;20:137-144.
5. Carson JL, Kelley MA, Duff A. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240-1245.
6. Urokinase Pulmonary Embolism Trial Group. Urokinase pulmonary embolism trial: phase 1 results: a cooperative study. JAMA. 1970;214: 2163-2172.
7. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990;81:1735-1743.
8. Lang IM, Marsh JJ, Olman MA, Moser KM, Loskutoff DJ, Schleef RR. Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli. Circulation. 1994;89:2715-2721.
9. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res. 1985;44:139-266.
10. Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G, Ploplis VA, Muller M, Nagy A, Plow EF, Gerard RD, Edgington TS, Risau W, Collen D. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann N Y Acad Sci. 1997;811:191-206.
11. Van Meijer M, Pannekoek H. Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis. 1995; 9:263-276.
12. Loskutoff DJ, Sawdey M, Mimuro J. Type 1 plasminogen activator inhibitor. In: Coller B, ed. Progress in Hemostasis and Thrombosis. Philadelphia, Pa: WB Saunders; 1988:87-115.
13. Loskutoff DJ, Sawdey M, Keeton M, Schneiderman J. Regulation of PAI-1 gene expression in vivo. Thromb Haemost. 1993;70:135-137.
14. Schneiderman J, Loskutoff DJ. Plasminogen activator inhibitors. Trends Cardiovasc Med. 1991;1:99-102.
15. Schleef RR, Lang IM, Gombau L. Platelet type 1 plasminogen activator inhibitor: an analysis of its functional status, the targeting to storage granules, and hemorrhagic disease mediated by the deficiency of this molecule. In: Aznar J, Estelles A, Gilabert J, eds. Fibrinolylic Inhibitors: Cellular, Biological and Clinical Aspects. Madrid, Spain: SA Grupo Masson; 1994:60-71.
16. Carmeliet P, Stassen JM, De Mol M, Declerq C, Bouche A, Collen D. Arterial neointima formation after trauma in mice with inactivation of the t-PA, u-PA or PAI-1 genes. Fibrinolysis. 1994;8:101. Abstract.
17. Eitzman DT, McCoy RD, Fay WP, Shen T. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 1996; 97:232-237.
18. Sawa H, Fujii S, Sobel BE. Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis. Arterioscler Thromb. 1992;12:1507-1515.
19. Schleef RR, Loskutoff DJ, Podor TJ. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells. J Cell Biol. 1991;113:1413-1423.
20. Garvey W, Fathi A, Bigelow F, Carpenter B, Jimenez C. A combined elastic, fibrin and collagen stain. Stain Technol. 1987;62:365-367.